Clinical Trial Update: A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing two high-dose-rate brachytherapy schedules in locally advanced squamous cell carcinoma of the cervix has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Cervix

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Squamous Cell Carcinoma of Cervix | Phase 3 | Status: COMPLETED